| GBM | Glioblastoma |
| WHO | World Health Organization |
| OXPHOS | Oxidative phosphorylation |
| TMZ | Temozolomide |
| BBB | Blood-brain barrier |
| 5hmC | 5-hydroxymethylcytosine |
| IDH1 | Isocitrate dehydrogenase 1 |
| PDGFRA | Platelet-Derived Growth Factor Receptor Alpha |
| ACVR1 | Activin A receptor type I |
| HDACs | Histone deacetylases |
| HATs | Acetyltransferases |
| DNMTi | DNA methylation inhibitors |
| PBMC | Peripheral blood mononuclear cells |
| PFS6 | Progression-free survival |
| VPA | Valproic acid |
| EMT | Epithelial-mesenchymal transition |
| BRD | Bromodomain |
| IDO | Indolamine 2,3-dioxygenase |
| BsAbs | Bispecific antibodies |
| TAAs | Tumor-associated antigens |
| ADCC | Antibody-dependent cytotoxicity |
| PRRs | Pattern recognition receptors |
| HSV-TK | Herpes simplex virus type 1 |
| DCVs | Dendritic cell vaccines |